|1.||Kuliev, Anver: 28 articles (02/2015 - 02/2002)|
|2.||Christie, Jason D: 25 articles (10/2015 - 01/2007)|
|3.||Verlinsky, Yury: 24 articles (07/2010 - 02/2002)|
|4.||Urade, Yoshihiro: 16 articles (01/2014 - 01/2002)|
|5.||Munné, Santiago: 16 articles (06/2012 - 03/2002)|
|6.||Kawut, Steven M: 15 articles (03/2014 - 12/2005)|
|7.||Ware, Lorraine B: 14 articles (02/2015 - 01/2007)|
|8.||Lung Transplant Outcomes Group: 14 articles (02/2015 - 11/2007)|
|9.||Diamond, Joshua M: 13 articles (10/2015 - 10/2010)|
|10.||Rechitsky, Svetlana: 13 articles (02/2015 - 02/2002)|
08/01/2014 - "In validation studies, we showed that CNV-Seq was highly sensitive and specific for detection of euploidy, aneuploidy, and segmental imbalances in 24 whole genome amplification samples from PGD embryos that were originally diagnosed by gold standard array comparative genomic hybridization. "
12/01/2011 - "Bisignano et al. (2011) argue that, for preimplantation genetic diagnosis (PGD) of aneuploidy for all 24 chromosomes, microarray-based comparative genomic hybridization (array CGH) is superior to the use of single-nucleotide polymorphism (SNP) genotyping arrays. "
04/01/2004 - "This study evaluates whether IVF-intracytoplasmic sperm injection (ICSI) results could be improved by selecting embryos through PGD-AS (aneuploidy screening) in couples in whom the male partner presents meiotic abnormalities. "
10/22/2001 - "The in vivo and in vitro efficiency and efficacy of PGD for aneuploidy."
10/01/2015 - "The aim of the study was to report the successful pregnancy outcome following PGD with NGS as the method for 24 chromosome aneuploidy screening in the case of Robertsonian translocation. "
|2.||Spontaneous Abortion (Miscarriage)
07/01/2007 - "In a parallel controlled study, PGD with NRR significantly improved implantation rates and reduced spontaneous abortions, showing that PGD is more efficient in selecting embryos that will reach term."
02/01/2015 - "This outcome is significantly different from that of our 2,064 PGD cycle series without concomitant 24-AT, including improved pregnancy (68.4% vs. 45.4%) and 3-fold spontaneous abortion reduction (5.5% vs. 15%) rates. "
07/01/2007 - "PGD with NRR significantly improved implantation rates, from 20% to 31%, and reduced spontaneous abortions from 27% to 6%. "
03/01/2002 - "PGD of translocations has been approached through a variety of methods, here reviewed, and has resulted in a significant reduction in spontaneous abortions. "
06/01/2000 - "PGD of translocations achieves a statistically significant reduction in spontaneous abortion, both for polar-body and blastomere biopsy cases. "
|3.||Primary Graft Dysfunction
06/01/2015 - "Outcome measures for lung recipients were early survival and primary graft dysfunction (PGD) rates. "
02/01/2015 - "We aimed to determine whether the pTLC ratio is associated with the risk of primary graft dysfunction (PGD) after bilateral LTx (BLT). "
11/01/2014 - "The odds of developing severe primary graft dysfunction (PGD) in the Heavy Alcohol Use group versus the No Alcohol Use group were 8.7 times greater (95% confidence interval 1.427 to 53.404, p = 0.019) after controlling for factors known to be associated with PGD. "
03/01/2014 - "Biologic pathways with significant genetic conservation across human populations have been implicated in the pathogenesis of primary graft dysfunction (PGD). "
02/01/2014 - "For recipients, early survival and the rate of primary graft dysfunction (PGD) grade 3 were the main outcome measures. "
06/01/2008 - "Moreover, there was a significantly greater proportion of patients during PGD treatment than BMT treatment showing improvements on adverse effects associated with hyperprolactinemia (56% vs 17%, P = 0.037). "
10/08/2015 - "Clinical trials have demonstrated the beneficial effects of Peony-Glycyrrhiza Decoction (PGD) in alleviating antipsychotic-induced hyperprolactinemia (hyperPRL) in schizophrenic patients. "
07/01/2015 - "Our previous studies have shown the therapeutic efficacy and underlying mechanisms of Peony-Glycyrrhiza Decoction (PGD), an herbal preparation, in treating antipsychotic-induced hyperprolactinemia in cultured cells, animal models, and human subjects. "
12/03/2012 - "Clinical studies have demonstrated the effectiveness of an herbal preparation called Peony-Glycyrrhiza Decoction (PGD) in alleviating antipsychotic-induced hyperprolactinemia (hyperPRL). "
06/01/2008 - "This study was designed to compare the herbal preparation called Peony-Glycyrrhiza Decoction (PGD) with bromocriptine (BMT), a dopamine agonist widely used for PRL-secreting disorders, in the treatment of risperidone-induced hyperprolactinemia. "
12/01/2008 - "Pharmacological tools, such as receptor-specific agonists and antagonists, and genetically-engineered mice, which lack either DP or CRTH2, have helped understand the complex effects of PGD(2) in allergic inflammation of the airways. "
01/01/2004 - "The findings from these in vivo and vitro studies suggest that PGD(2) secreted from activated mast cells may be involved in the formation and/or maintenance of allergic inflammations through its dual receptor systems."
01/01/2004 - "The involvement of PGD(2) in allergic inflammation has been corroborated by several studies. "
10/01/2015 - "Taken together, these results demonstrate that the use of PGD(2) and its metabolites in the resolution of inflammation was established before the divergence of fish from tetrapods more than 450 million years ago and support a critical role for granulocytes in the resolution of inflammation in vertebrates."
03/01/2012 - "In a sheep model of allergic inflammation, inhalation of PF-5212372 significantly inhibited late-phase bronchoconstriction (78% inhibition; p < 0.001) and airway hyper-responsiveness (94% inhibition; p < 0.001), and isolated sheep lung mast cell assays confirmed species translation via effective inhibition of PGD(2) release (0.78 nM). "
|1.||Plant Preparations (Preparation, Plant)
|2.||Niacin (Nicotinic Acid)
|4.||hypohidrotic Ectodermal dysplasia with immune deficiency
|7.||Transforming Growth Factor beta (TGF-beta)
|8.||Prostaglandins E (PGE)
|2.||Deep Brain Stimulation
|5.||Transplantation (Transplant Recipients)